Petri Dish: Boston Scientific CFO retires; Biotech undergoes 1-for-20 reverse stock split
Over the last week, Boston Scientific announced a forthcoming CFO change, Seres' reverse stock split and a Flagship startup's new pharma partnership. |!| Boston